Status:
NOT_YET_RECRUITING
The Effect of Sarcopenic Obesity on Sleep in Individuals With Obesity Hypoventilation Syndrome
Lead Sponsor:
Istanbul University
Collaborating Sponsors:
Istanbul University - Cerrahpasa
Conditions:
Obesity Hypoventilation Syndrome (OHS)
Obesity
Eligibility:
All Genders
50+ years
Brief Summary
Obesity Hypoventilation Syndrome(OHS) is characterized by daytime hypercapnia and sleep-disordered breathing without other causes of hypoventilation in individuals with a body mass index above 30 kg/m...
Detailed Description
Individuals with Obesity Hypoventilation Syndrome followed up in Istanbul University Faculty of Medicine, Department of Chest Diseases will be included in the study. Cases will be divided into two gro...
Eligibility Criteria
Inclusion
- \>50 years old
- 30\< BMI\< 45 kg/m2
- Patients who have undergone polysomnography evaluation within the last 6 months
Exclusion
- Patient who have immobilized for more than 15 days in the last 6 months
- Patient who have used corticosteroids in the last 6 months
- Patient who have been significant weight loss in the last 6 months
- Patient who have been significant serious comorbidities (cognitive impairments, neuromuscular diseases, unstable heart problems, uncontrolled respiratory problems, unresolved thyroid problems, etc.) that may affect participation in the study
Key Trial Info
Start Date :
July 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06136533
Start Date
July 10 2025
End Date
October 1 2025
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University-Cerrahpasa
Istanbul, Turkey (Türkiye), 34320